Thu-18-11-2021, 20:25 PM
Update: The European Commission has approved Skyrizi for psoriatic arthritis.
The Marketing Authorization will be valid in all member states of the European Union, as well as Iceland, Liechtenstein, Norway and Northern Ireland.
The Marketing Authorization will be valid in all member states of the European Union, as well as Iceland, Liechtenstein, Norway and Northern Ireland.